Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.45 |
| ▸ | ACACB | O00763 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809995 | 0.94 | CA2 (0.49) | CA2CA12CA1CA9ACACB | |
| SCHEMBL6540991 | 0.90 | CA2 (0.53) | CA2ACACB | |
| SCHEMBL6540106 | 0.86 | KMT2A (0.50) | CA2CA12CA1CA9 | |
| SCHEMBL6539692 | 0.86 | KMT2A (0.50) | CA2CA12CA1CA9 | |
| SCHEMBL6810119 | 0.85 | CA2 (0.48) | CA2CA12CA1CA9ACACB | |
| SCHEMBL6680578 | 0.83 | HPGD (0.42) | CA12CA9NR1H2 | |
| SCHEMBL9467853 | 0.80 | CYP1A2 (0.54) | CA2CA12CA1CA9 | |
| SCHEMBL27542212 | 0.79 | NPC1 (0.52) | — | |
| SCHEMBL6677489 | 0.79 | ALDH1A1 (0.47) | CA2CA12CA1CA9ACACB | |
| SCHEMBL6677426 | 0.79 | ADRB3 (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | CA2 696/4885CA12 1959/4885CA1 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.